Human Gene AMFR (ENST00000290649.10) Description and Page Index
  Description: Homo sapiens autocrine motility factor receptor (AMFR), transcript variant 4, mRNA. (from RefSeq NM_001323512)
Gencode Transcript: ENST00000290649.10
Gencode Gene: ENSG00000159461.15
Transcript (Including UTRs)
   Position: hg38 chr16:56,361,452-56,425,545 Size: 64,094 Total Exon Count: 14 Strand: -
Coding Region
   Position: hg38 chr16:56,362,909-56,425,327 Size: 62,419 Coding Exon Count: 14 

Page IndexSequence and LinksUniProtKB CommentsProtein StructureOther NamesMethods
Data last updated at UCSC: 2021-06-20 19:51:40

+  Sequence and Links to Tools and Databases
  Press "+" in the title bar above to open this section.

-  Comments and Description Text from UniProtKB
  ID: AMFR_HUMAN
DESCRIPTION: RecName: Full=E3 ubiquitin-protein ligase AMFR; EC=6.3.2.-; AltName: Full=Autocrine motility factor receptor; Short=AMF receptor; AltName: Full=RING finger protein 45; AltName: Full=gp78;
FUNCTION: E3 ubiquitin-protein ligase that mediates the polyubiquitination of a number of proteins such as CD3D, CYP3A4, CFTR and APOB for proteasomal degradation. Component of a VCP/p97- AMFR/gp78 complex that participates in the final step of endoplasmic reticulum-associated degradation (ERAD). The VCP/p97- AMFR/gp78 complex is involved in the sterol-accelerated ERAD degradation of HMGCR through binding to the HMGCR-INSIG complex at the ER membrane and initiating ubiquitination of HMGCR. The ubiquitinated HMGCR is then released from the ER by the complex into the cytosol for subsequent destruction. Also acts as a scaffold protein to assemble a complex that couples ubiquitination, retranslocation and deglycosylation. Mediates tumor invasion and metastasis as a receptor for the GPI/autocrine motility factor.
PATHWAY: Protein modification; protein ubiquitination.
SUBUNIT: Interacts with RNF5. Also forms an ERAD complex containing VCP/p97, NGLY1; PSMC1; SAKS1 AND RAD23B required for coupling retrotranslocation, ubiquitination and deglycosylation (By similarity). Interacts with DRL1. Interacts (through a region distinct from the RING finger) with UBE2G2/UBC7. Component of the VCP/p97-AMFR/gp78 complex that enhances VCP/p97 binding to polyubiquitinated proteins for their degradation by the endoplasmic reticulum-associated degradation (ERAD) pathway. Interacts (via the VIM) with VCP/p97. Interacts (via its membrane domain) with INSIG1; the interaction initiates the sterol-mediated ubiquitination and degradation of HMGCR by the ERAD pathway.
INTERACTION: P55072:VCP; NbExp=6; IntAct=EBI-1046379, EBI-355164;
SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass membrane protein.
DOMAIN: The VCP/p97-interacting motif (VIM) is sufficient for binding VCP/p97 to form a complex capable of transfering VCP/p97 from the cytosol to microsomes.
SIMILARITY: Contains 1 CUE domain.
SIMILARITY: Contains 1 RING-type zinc finger.
SEQUENCE CAUTION: Sequence=AAA36671.1; Type=Miscellaneous discrepancy; Note=Several sequencing errors; Sequence=AAA79362.1; Type=Frameshift; Positions=355, 388, 411, 487, 537, 583, 632;

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR026608 - Amfr
IPR003892 - CUE
IPR001841 - Znf_RING
IPR013083 - Znf_RING/FYVE/PHD

Pfam Domains:
PF02845 - CUE domain
PF13639 - Ring finger domain

Protein Data Bank (PDB) 3-D Structure
MuPIT help

2EJS
- NMR

3FSH
- X-ray

3H8K
- X-ray
To conserve bandwidth, only the images from the first 3 structures are shown.
3TIW - X-ray 4G3O - X-ray


ModBase Predicted Comparative 3D Structure on Q9UKV5
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Other Names for This Gene
  UCSC ID: ENST00000290649.10
Representative RNA: NM_001323512
Protein: Q9UKV5 (aka AMFR_HUMAN)

+  Methods, Credits, and Use Restrictions
  Press "+" in the title bar above to open this section.